THE TAPE
TFX · Medical Instruments · $6.7B

Teleflex Incorporated

$157.10▲ +1.29%
Last close
Relative strength
85RS
of 99, against every stock▲ +37 on the month
Powering up
Turning
−8.2%
six months against Medical Instruments
52-week range
−0.3%
from the high
$100.18$157.65
Setup
+8.3%
against the pivot at $145.00
No report date on the calendar.
Growth FLATProof PENDING
Quarter to Sep 30, revenue +0% on a year ago
11/16 O 155.00 H 157.65 L 154.63 Vol 799.6K
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

All four are in order, fastest above slowest — every timeframe pointing the same way.

RS85
vs pivot+8.34%
Tightening1.23×
Dry-up0.89×
Up/down vol-0.04
From high0%
climbing6 of 9checks
Previous breakout trailed out ▼ −5.57% in Aug
Powering up
Support and resistance
Support below
$144.05
-8.3% · tested 4× · last 11 sessions ago
Resistance above
None within the last 120 sessions

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 12.6 weeks and fell 18% from its ceiling at its deepest. The pivot is $145.00, and the stock closed 8.3% above that pivot. Its relative strength rating is 85.

Against its industry
TurningBehind its industry over six months, but ahead over one and three.
One month against its industry
+15.7%
Three months against its industry
+18.9%
Six months against its industry
-8.2%

Read against an equal-weighted index of Medical Instruments, which is +31.0% against the S&P 500 over six months Fully aligned.

Also on
Peers
Same theme
No themes — common and fine.
Catalyst roadmap
0
days
Ex-dividend today
Nov 16, 2026
  1. Ex-dividendconfirmedin 0d
    Ex-dividend date
    Nov 16, 2026
How it moves on earnings

On average 8.3% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$2.3B
+0.1% year on year
Operating margin
9.4%
gross 58.3%
Net margin
13.5%
Free cash flow
—
Price to sales
2.95×
Price to earnings
21.9×

Twelve months to Sep 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Nov 5
Key takeaway
A mixed quarter: the numbers do not agree.
Revenue
$567.8M
-0.4% QoQ · +0.1% YoY
Gross margin
65.0%
+6.8 pts QoQ
Net income
$927.4M
Positive
Free cash flow
—

What the numbers say

  • Revenue +0.1% year over year, -0.4% on the quarter
  • Good: Gross margin 65.0%, +6.8 points on the quarter
  • Good: Profitable: net income $927M, operating margin 18.6%
  • Good: Share count -5.9% in a year: buying back
  • Weak: Net debt $1.19B · cash $430M
Revenue by quarter
Net income
shares -5.9% in a year · net debt $1.2B

The desk’s own read

Flagged as drifting up since the report

Final read
Growth: FLAT · Economic proof: PENDING
Key question: What turns the cash flow positive?
The next test is the balance sheet: net debt $1.19B · cash $430M.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 1 of 46 tracked funds at the end of Q3 2026.

Last quarter: 1 added, 1 sold out.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
GappedTape · 2026-11-05
+7.1%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Moved 5%+ up on earningsTape · 2026-11-05
+7.1% on earnings 2026-11-04
No measurable effect: stocks behave like random ones over the next three sessions (604 cases over 42 nights).
Earnings comingEvent · 2026-11-04
reports 2026-11-05 bmo
No measurable effect: stocks behave like random ones over the next three sessions (2,970 cases over 40 nights).
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-04
above 20d & 50d on 1.7x volume at 139.95
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
Earnings date movedEvent · 2026-10-24
2026-11-04 -> 2026-11-05
No measurable effect: stocks behave like random ones over the next three sessions (2,989 cases over 51 nights).
Earnings date movedEvent · 2026-10-21
2026-11-04 -> 2026-10-22
No measurable effect: stocks behave like random ones over the next three sessions (2,989 cases over 51 nights).
Earnings comingEvent · 2026-10-21
reports 2026-10-22 bmo
No measurable effect: stocks behave like random ones over the next three sessions (2,970 cases over 40 nights).
Earnings date movedEvent · 2026-10-20
2026-10-22 -> 2026-11-04
No measurable effect: stocks behave like random ones over the next three sessions (2,989 cases over 51 nights).

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders

Nobody bought or sold on the open market in the last 6 months. There were 5 filings for awards, option exercises or shares withheld to pay tax — those happen on a vesting schedule, so they are not a decision to buy or sell.

Most recent filings
2026-09-08 Salmon Sean · Directoraward674
2026-06-08 RANDLE STUART A · Directoraward995
2026-06-08 RANDLE STUART A · Directoraward4,663
2026-06-08 Weidman Jason R. · President and CEO, Directoraward53,983
2026-06-07 RANDLE STUART A · Directorwithheld for tax4,054$526,371

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

The geometry
Level · ceiling$156.75
The pole · over 5 sessions+11.0%
Through to the apex · the lines run parallel, so they never meetn/a
Touches · swing points the lines are drawn through3 up · 3 down
Length0.6 weeks
What lines up

6 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy4
Buy2
Hold6
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

Checking your subscription…

X-ray
13w · 18%

The most recent of 3 completed bases.

Checking your subscription…

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Teleflex Incorporated (TFX) — The Tape